Background Carotid intima-media thickness (cIMT) is related to the risk of cardiovascular events in the general population. An association between changes in cIMT and cardiovascular risk is frequently assumed but has rarely been reported. Our aim was to test this association.
Introduction
Carotid intima-media thickness (cIMT) is a non-invasive ultrasound biomarker of early atherosclerosis. A positive association exists between it and the risk of sub sequent cardiovascular events in general populations, independent of all major risk factors. 1 This relation has promoted the use of cIMT in pathophysiological studies and clinical trials, in which the perception of cIMT has shifted from a secondary endpoint to a surrogate of risk of cardiovascular event. A randomised clinical trial published in 2009 was prematurely stopped on the basis of cIMT results. 2 Many studies already include the tacit assumption that relations with cIMT, as seen in the general population or risk cohorts, refl ect associations with the risk of cardiovascular events. [3] [4] [5] Most of these studies use cIMT progression, calculated as an absolute yearly rate of progression. Repeated cIMT measurements are a plausible way to test the eff ects of interventions on cIMT progression. However, whether change of cIMT aff ects the risk of cardiovascular events should be systematically investigated.
The results of the Multi-Ethnic Study of Atherosclerosis 6 show a positive association between cIMT progression and stroke. The association between cIMT progression and the risk of myocardial infarction or mortality in the general population has never been assessed on a large scale. In view of the large variability of cIMT progression, this task requires access to individual participant data from many large cohorts. The aim of the fi rst stage of the PROG-IMT project (individual progression of carotid intima media thickness as a surrogate of vascular risk) is to assemble a large cIMT progression dataset from general populations and to analyse the association of cIMT progression with the risk of cardiovascular events, the results of which we present here. In further stages we will analyse high-risk populations and randomised controlled trials.
7
Methods

Study identifi cation and procedures
We comprehensively searched published work for studies that had the following inclusion criteria: longitudinal observational studies, sample of or similar to the general population, well-defi ned inclusion criteria and recruitment strategy, at least two ultrasound visits with assessment of cIMT, clinical follow-up after the second ultrasound visit recording myocardial infarction, stroke, death, vascular death, or a combination of these, and a minimum of 20 events for at least one endpoint. We searched PubMed with "intima media" AND ("myocardial infarction" OR "stroke" OR "death" OR "mortality") to fi nd original articles (usually 3000-5000 words) or research reports (usually 1000-1500 words) of relevant studies. We included publications in all lan guages, published up to Jan 10, 2012. We also manually searched reports referenced in reviews of cIMT. We sent a short screening questionnaire to the authors of potentially relevant reports. If a study fulfi lled all inclusion criteria, the study team was invited to participate, contribute a predefi ned set of variables for individual participants, and collaborate on the project's objectives. 7 The datasets underwent central plausibility checks, in which the cutoff thresholds to defi ne implausible values were discussed with the investigators and data managers of the individual studies. The data were also harmonised, in which variables were uniformly named, transformed to SI units, and ordinal variables were recoded into binary categories with balanced distributions. Mean common carotid artery intima-media thickness was defi ned as the average of all mean intimamedia thicknesses of the common carotid artery at one timepoint (including the left and the right common carotid artery, the near and far wall, and all insonation angles). Similarly, maximal common carotid artery intima-media thickness was defi ned as the average of all maximal common carotid artery intima-media thicknesses. Mean maximal intima-media thickness was defi ned as the mean of maximal common carotid artery intima-media thickness, maximal intima-media thickness of the carotid bifurcation, and maximal intima-media thickness of the internal carotid artery. From these variables, we calculated the yearly progression rate for two ultrasound scans, and the mean of both scans.
The clinical endpoints (myocardial infarction, stroke, vascular death, and total mortality) were defi ned as in the individual studies. We included probable or defi nite myocardial infarction and any stroke (symptoms lasting more than 24 h, including non-traumatic haemorrhage).
Statistical analysis
To assess the risk of the fi rst cardiovascular event, we excluded all individuals who had a stroke or myocardial infarction before the second cIMT scan. For each study, we fi tted Cox regression models for each endpoint: myocardial infarction, stroke, death, and the combined endpoint (myocardial infarction, stroke, or vascular death). In studies for which vascular death was not assessed, we included total mortality. Each model estimated the hazard ratio (HR) of the cIMT progression variable per studyspecifi c SD. Model 1 adjusted for age and sex; model 2 also adjusted for the mean cIMT of the fi rst and the second scan. Model 3 included variables from model 2 and also adjusted for ethnic origin and socioeconomic status, and model 4 included variables from model 3 plus the mean and the progression of vascular risk factors (systolic blood pressure, antihypertensive treatment, total cholesterol, lipid-lowering treatment, creatinine concentration, haemoglobin concen tration, smoking, and diabetes). We pooled the log HR estimates of the diff erent studies by random eff ects meta-analysis 8 and displayed them in forest plots. Heterogeneity was assessed with the I² statistic. 9 We used multiple imputation for missing values with ten imputed datasets per study. 10 Ultrasound data, conventional risk factors, and endpoint data were used in the imputation together, 11 but endpoint data were not imputed. Risk factor variables with more than 20% of values missing were neither imputed nor used in the analyses. As a result, of 194 risk factor variables in 17 cohorts, eight variables in fi ve cohorts were lost: six variables were aff ected in only one of two visits (baseline or follow-up), two variables were dropped for both visits. cIMT values were imputed and used if the individual variable had more than 80% valid values or if the cIMT variables of one carotid segment at one visit had at least one valid value in more than 95% of participants, which was the case in all cohorts. The main analyses were repeated with non-imputed datasets in sensitivity analyses.
To corroborate our analyses, we did several sensitivity analyses. In addition to HR per one SD diff erence of cIMT progression, we estimated HR per 0·1 mm diff erence of cIMT progression. Because the cIMT progression variables had a non-normal distri bution with wide tails, we repeated the analyses with a normalising transformation, preserving the ranks, to address potential eff ects of outliers. The proportional hazard assumption was assessed with an interaction term between cIMT progression and follow-up time from the second cIMT to event. To account for diff erential eff ects of age, we investigated the eff ect of an interaction term of age and cIMT progression. To account for potential sex diff erences, we repeated the analyses stratifi ed by sex. A potential dose-response eff ect was assessed by analysis of cIMT and progression in quintiles.
In studies that did more than two ultrasound scans, individual cIMT progression was reassessed on the basis of three (or more) measurements by linear regression, excluding individuals who had had stroke or myocardial infarction before the last scan. These progression estimates were compared with those relying on two measurements and, when endpoints were recorded after the third scan, Cox regression models were repeated. For studies with four ultrasound visits, the reproducibility of assessment of cIMT progression was estimated by comparison of the fi rst-to-second progression and thirdto-fourth progression. Study selection bias was assessed by funnel plots. 12 At the study level, we used metaregression to investigate the associations between cIMT reproducibility or year of fi rst ultrasound examination, and log HR of cIMT progression. 13 The principal analysis and much of the sensitivity analyses used a previously published predefi ned analysis plan. 7 All analyses were done with Stata/IC (version 11.1) or SPSS (version 19).
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. MWL and SGT had full access to all the data in the study and MWL had fi nal responsibility for the decision to submit for publication.
Results
The publication search yielded 1649 reports. 22 co horts fulfi lled the inclusion criteria (appendix p 11); 16 of which provided individual participant data and were included (table 1). Six study groups declined to participate (appendix p 1). Included cohorts had 58 407 participants and 625 593 person-years of follow-up, studies not included had 30 351 participants and 254 130 person-years.
Thus, data included are 66% of data available worldwide in terms of number of participants, and 71% in terms of person-years of follow-up. Comparison of the characterstics of the studies included (table 1) and not included (appendix p 1) provides no indication of selection bias. After exclusion of individuals with previous events and events before the second ultrasound, and counting only the follow-up time after the second ultrasound scan (appendix p 2), the cohorts included 36 984 individuals with 257 067 person-years of follow-up. On average, people included were younger and had lower risk factors than were those who were excluded. 1519 myocardial infarctions, 1339 strokes, and 4268 deaths occurred, and 2028 participants reached the combined endpoint (myocardial infarction, stroke, or vascular death).
Most participants were white, although other ethnic origins were also well represented (table 1). The sampling and endpoint identifi cation procedures were of a high standard, although diff erences did exist (appendix p 3). The diff erent cohorts and their study protocols had multiple potential sources of heterogeneity, including diff erent age ranges (table 1) , ultrasound protocols (table 1, appendix pp 4, 12), and endpoint defi nitions (appen dix pp 5-6). Although the defi nition of other segments diff ered, the region designated "common carotid artery" was relatively consistent (appendix p 12). One study restricted the measurements to one side, and six included near and far wall measurements of cIMT. Ten studies used semi-automated edge-detection algorithms.
The mean estimates of cIMT progression ranged from 0·001 to 0·030 mm per year for mean common carotid artery intima-media thickness, from 0·001 to 0·065 mm per year for maximal common carotid CCA=common carotid artery. BIF=carotid bifurcation. ICA=internal carotid artery. *Reasons for exclusion were myocardial infarction, stroke, or death before the second ultrasound visit, or fewer than two ultrasound scans. †After exclusion. ‡Time between fi rst and second ultrasound scan. §Declined to participate, public-use dataset included. ¶Excluded from mean common carotid artery intima-media thickness analyses because it had not assessed mean carotid intima-media thickness at two ultrasound scans. ||The Cardiovascular Health Study consists of two cohorts, one of white participants and one of African American participants that was begun 3 years later, when the fi rst follow-up visit of the white cohort was due. They were treated as diff erent cohorts in all subsequent analyses. **A small sample was included because of the need to await adjudication of outcome events by the study neurologists and cardiologists at the time of analyses. No inference should be made about conclusions regarding the full sample. † †No myocardial infarctions happened after exclusion of the events that occurred before the second scan.
Table 1: Included studies
See Online for appendix artery intima-media thickness, and from 0·000 to 0·023 mm per year for mean maximal intima-media thickness (appendix pp 7-8). Overall, intima-media thickness (mean of baseline and follow-up) had only a very weak correlation with yearly intima-media thickness progression (r ranged from -0·38 to 0·25). The average reproducibility of cIMT (correlations between two examinations) ranged from r=0·27 to r=0·84. Figure 1 shows the association between mean common carotid artery intima-media thickness progression and the four endpoints in the fully adjusted model (model 4). The overall estimated HR per one SD increase in mean common carotid intima-media thickness progression for the combined endpoint was 0·97 (95% CI 0·94-1·00) when adjusted for age, sex, and mean common carotid artery intima-media thickness, and 0·98 (0·95-1·01) when also adjusted for vascular risk factors. We observed no heterogeneity in the HRs between studies. Figure 2 shows the same analyses for the mean common carotid artery intima-media thickness. The HRs per one SD increase for the combined endpoint were 1·24 (1·16-1·32) when adjusted for age, sex, and mean common carotid artery intima-media thickness pro gression, and 1·16 (1·10-1·22) when also adjusted for vascular risk factors. Some heterogeneity was evident when the mean cIMT HRs were combined. Table 2 shows the results of the primary analyses (for the results of the sensitivity analyses see appendix p 9). Irrespective of the defi nition of cIMT (mean common carotid artery intima-media thickness, maxi mal common carotid artery intima-media thickness, mean maximal intima-media thickness), the endpoint, and adjustment, no signifi cant association existed between cIMT progression and any endpoints. The association of cIMT (mean of baseline and follow-up) with the endpoints was signifi cant and positive. These associations were attenuated after adjustment for vascular risk factors, as expected. Some analyses showed signifi cant heterogeneity in the HRs across studies. The calculation of the HRs per 0·1 mm instead of one SD, the use of nonimputed data, or the use of a normalising trans formation of the cIMT progression distribution did not qualitatively change any of the results (appendix p 9). When cIMT progression was categorised in quintiles (fi gure 3A), no signifi cant association existed with the combined endpoint, by contrast with mean cIMT (fi gure 3B). In analyses stratifi ed by sex, no evidence existed of an association between cIMT progression and the endpoints for either sex (appendix p 9 eff ects of age. The main results from studies including plaques in the cIMT measurement did not diff er from studies avoiding plaques (appendix p 9). No evidence existed of non-proportional hazards over time for cIMT progression or for mean cIMT. Finally, the principal analysis for stroke was repeated including published estimates from the Multi-Ethnic Study of Atherosclerosis, 6 which pro vided much the same overall results (appendix p 9).
From the studies with more than two ultrasound visits, we recalculated the yearly cIMT progression rate including three or four cIMTs and compared them with those assessed from two ultrasound scans (appendix p 10). The SD of the estimates of cIMT progression decreased when three or four measurements were included. On the basis of reassessed cIMT progression estimates and only including clinical events after the third ultrasound scan, the HR for cIMT progression was recalculated in four cohorts with available clinical follow-up after the third ultrasound visit. The HR estimates from two ultrasound visits and from three ultrasound visits had only small diff erences in inconsistent directions (appendix p 13). The reproducibility correlations of cIMT progression for the cohorts with four ultrasound visits were -0·02 for Atherosclerosis Risk in Communities, 15 -0·04 for Interventionsprojekt zerebro vaskuläre Erkrankungen und Demenz im Landkreis Ebersberg, 22 and -0·06 for the Kuopio Ischaemic Heart Disease study (appendix pp 7-8); 23 all were near zero.
Omission of two studies indicative of selection bias (appendix p 14) did not change the overall results. A meta-regression analysis did not suggest any eff ect of cIMT reproducibility or year of fi rst ultrasound on the HRs for cIMT progression (appendix p 15).
Discussion
We have collated 71% of the data from general population cohort studies available worldwide, and have been able to undertake comprehensive and standardised analysis on the basis of individual participant records.
Yearly carotid intima-media thickness progression
Mean carotid intima-media thickness of scans 1 and 2
Overall HR (95% CI) We found no evidence of an association between individual cIMT progression and the risk of subsequent cardiovascular events, irrespective of defi nition of cIMT, endpoint, and adjustment. By contrast with these results, the Multi-Ethnic Study of Atherosclerosis 6 had a signifi cant and positive association between yearly mean common carotid artery intima-media thickness progression and risk of stroke. Combin ation of Multi-Ethnic Study of Atherosclerosis resultsbased on 42 strokes-with the data for 1339 strokes from our 16 studies provided a non-signifi cant association (HR 1·02, 95% CI 0·96-1·09). An eff ect dependent on ethnic origin seems highly unlikely, because the three most common ethnic origins in the Multi-Ethnic Study of Atherosclerosis were also present in our cohorts, and the fourth (Chinese) had only one stroke event. The possibility of a spurious fi nding in the Multi-Ethnic Study of Atherosclerosis should not be excluded.
By contrast with our consistent null result for cIMT progression, a positive, robust, and statistically signifi cant association exists between mean cIMT and subsequent clinical endpoints. What are the possible methodological or biological explanations?
Diff erences between study procedures, ultrasound protocols, endpoint defi nitions, or durations of ultrasound and clinical follow-up could aff ect the progression estimates and their precision. However, the defi nition of common carotid artery intima-media thickness used in the primary and most secondary analyses was much the same in most studies (appendix p 12). The endpoint procedures and defi nitions diff ered only slightly, and most studies used expert adjudications to assess events. We found no evidence of statistical heterogeneity between the cIMT progression HRs. The diff erences in the rates of events could be explained by diff erent characteristics of the populations, including their age distributions.
All included studies took several steps to minimise measurement errors (appendix p 4). Nevertheless, cIMT progression as assessed from two ultrasound scans several years apart does not seem to be a reliable measure, irrespective of how modern and accurate the cIMT measurements were. This reduced reliability seems to be a more plausible methodological explanation for our negative result than is heterogeneity between studies.
Biological factors could explain the absence of relation between cIMT progression and clinical endpoints. Atherosclerosis is a lifelong process that progresses slowly at a young age, and could accelerate with accumulation of risk factors. 30 Slow progression of cIMT in healthy populations is diffi cult to detect. In intermediate stages, the diff use thickening of the intimamedia complex can become superimposed by focal plaques at vessel sites with the highest cIMT. 31 The diff use (cIMT) and focal (plaque) manifestations of atherosclerosis could have diff erent associations with risk factors. [32] [33] [34] The fi nal occurrence of clinical endpoints could be more strongly related to plaque formation than to cIMT progression. 35 Participation in a longitudinal population study might change an individual's behaviour, an eff ect known as the Hawthorne eff ect. 36 Lifestyle changes could have had complex eff ects-on cIMT progression, stabilisation of plaques, and improved survival-that are diffi cult to adjust for, diluting the association between cIMT change and clinical events. However, such behavioural eff ects are more plausible in high-risk populations than in the general population. Changing behaviour by motivational carotid ultrasound has not been substantiated for smoking cessation. 37 Moreover, only six of 16 studies informed participants of their cIMTs, which makes the Hawthorne eff ect unlikely.
The ethnic origins of participants were typical for the locations of the cohorts, so our results are only generalisable to the USA and Europe. Survivor bias was inevitably introduced by the need to exclude individuals with previous cardiovascular events and fewer than two ultrasound scans.
In conclusion, the association between individual cIMT progression and cardiovascular risk in the general population is still unproven, despite the strong association between single cIMT measurement and cardiovascular disease, 1, 38 as shown again in this study. We strongly advocate further validations and improvements of ultrasound protocols. Although eff orts have been made to develop standardised ultrasound protocols for single and repeated cIMT assessments, 39 methodological issues have only begun to be addressed. [40] [41] [42] [43] In population studies, ultrasound scans are typically repeated 2-5 years apart. More frequent cIMT measurements could increase the precision of the assessment of cIMT progression. If ultrasound protocols and study designs to minimise measurement errors are combined and carefully validated, cIMT progression in population studies could become a more reproducible biomarker.
Our results do not permit conclusions to be made about the surrogacy of cIMT progression in randomised controlled trials, which involve important diff erences in ultrasound assessment and population characteristics. This issue will be addressed in stage three of the PROG-IMT study.
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